window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

CDMO

  • Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain,Medical devices,Pharmaceuticals and therapeutics

    MGS launches A.i.r. platform delivering customizable auto-injector solutions

    MGS has launched the A.i.r. Platform, a new customizable auto-injector [...]

    May 5, 2026
  • Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Tjoapack expands oral solid dose bottle packaging capacity at Netherlands facility

    Tjoapack is expanding its oral solid dose bottle packaging capabilities [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Vetter advances launch preparations for V-OVS next tamper-evident syringe closure system

    Vetter has reached several development and verification milestones as it [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Therapeutic Areas

    Symbiosis manufactures first commercial-scale batch at new Stirling facility

    Symbiosis Pharmaceutical Services has completed its first commercial-scale manufacturing run [...]

    May 5, 2026
  • Manufacturing & Supply Chain

    Symbiosis receives King’s Award for Enterprise recognising international growth

    Symbiosis Pharmaceutical Services has been formally presented with a 2025 [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Cytovance Biologics celebrates 20 years advancing biopharma manufacturing in Oklahoma City

    Cytovance Biologics, a contract development and manufacturing organisation serving the [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Lonza to acquire Redberry to expand rapid microbiology testing for pharmaceutical quality control

    Lonza has signed an agreement to acquire Redberry, a French [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Manufacturing & Supply Chain

    KBI Biopharma CBO Katie Edgar on ADCs, biologics, and digital innovation in drug development

    Discover Pharma caught up with Katie Edgar, chief business officer [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Manufacturing & Supply Chain

    Pharma leaders on AI, automation, and ESG: How CDMOs are reshaping development at CPHI Frankfurt 2025

    At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Opinion & Events,Pharmaceuticals and therapeutics

    Personal connections at CPhI Frankfurt 2025: How trust drives long-term pharma relationships

    A roundtable at CPhI Frankfurt 2025 with industry leaders from [...]

    May 5, 2026
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Polaryx advances Phase 2 trial of PLX-200 in four rare diseases
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Lumen Bioscience gets up to $7M to advance LMN-1001 into Phase 1
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • Brainomix to present five ILD studies on quantitative CT at ERS Congress
    Categories: Advanced Therapies, Clinical & Regulatory, Digital & Data, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top